Earnings Feed
Start Free
Home/Filings/4/0001082504-04-000067
4//SEC Filing

CAMBRIDGE HEART INC 4

Accession 0001082504-04-000067

CIK 0000913443operating
View on SEC.govCompany Profile

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 2:17 PM ET

Size

20.0 KB

Accession

0001082504-04-000067

Insider Transaction Report

Form 4
Period: 2004-12-16
CAMBRIDGE HEART INCCAMH
BLUMBERG LOUIS
10% Owner
Transactions
  • Sale

    Common Stock

    2004-12-16$0.45/sh−103,400$46,530→ 1,900 total(indirect: See footnotes)
Holdings

  • Common Stock

    (indirect: See footnotes)
    316,500

  • Common Stock

    (indirect: See footnotes)
    776,906

  • Long Warrants

    (indirect: See footnotes)
    Exercise: $0.03Exp: 2009-01-01→ Common Stock (233,064 underlying)
    233,064

  • Common Stock

    (indirect: See footnotes)
    105,339

  • Long Warrants

    (indirect: See footnotes)
    Exercise: $0.03Exp: 2009-01-01→ Common Stock (31,590 underlying)
    31,590

  • Series A Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.34→ Common Stock (226,241 underlying)
    226,241

  • Long Warrants

    (indirect: See footnotes)
    Exercise: $0.03Exp: 2009-01-01→ Common Stock (67,872 underlying)
    67,872
BLUMBERG LAURENCE J
10% Owner
Transactions
  • Sale

    Common Stock

    2004-12-16$0.45/sh−103,400$46,530→ 1,900 total(indirect: See footnotes)
Holdings

  • Long Warrants

    (indirect: See footnotes)
    Exercise: $0.03Exp: 2009-01-01→ Common Stock (67,872 underlying)
    67,872

  • Common Stock

    (indirect: See footnotes)
    776,906

  • Common Stock

    (indirect: See footnotes)
    105,339

  • Long Warrants

    (indirect: See footnotes)
    Exercise: $0.03Exp: 2009-01-01→ Common Stock (233,064 underlying)
    233,064

  • Long Warrants

    (indirect: See footnotes)
    Exercise: $0.03Exp: 2009-01-01→ Common Stock (31,590 underlying)
    31,590

  • Series A Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.34→ Common Stock (226,241 underlying)
    226,241

  • Common Stock

    (indirect: See footnotes)
    316,500
AFB FUND LLC
10% Owner
Transactions
  • Sale

    Common Stock

    2004-12-16$0.45/sh−103,400$46,530→ 1,900 total(indirect: See footnotes)
Holdings

  • Long Warrants

    (indirect: See footnotes)
    Exercise: $0.03Exp: 2009-01-01→ Common Stock (31,590 underlying)
    31,590

  • Long Warrants

    (indirect: See footnotes)
    Exercise: $0.03Exp: 2009-01-01→ Common Stock (67,872 underlying)
    67,872

  • Series A Preferred Stock

    (indirect: See footnotes)
    Exercise: $0.34→ Common Stock (226,241 underlying)
    226,241

  • Common Stock

    (indirect: See footnotes)
    316,500

  • Common Stock

    (indirect: See footnotes)
    776,906

  • Common Stock

    (indirect: See footnotes)
    105,339

  • Long Warrants

    (indirect: See footnotes)
    Exercise: $0.03Exp: 2009-01-01→ Common Stock (233,064 underlying)
    233,064
Footnotes (14)
  • [F1]Each of the Reporting Person and the joint filers (individually), each a "Reporting Person" and collectively, the "Reporting Persons") disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. The Reporting Persons may be deemed to be a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, and are reporting beneficial ownership of the securities held by each of the other Reporting Persons as if beneficially owned by each Reporting Person.
  • [F10]Laurence J. Blumberg is the managing member of BCM and BCA. By virtue of his position as the managing member of BCM and BCA, Laurence J. Blumberg may be deemed to beneficially own the securities held by BLSF and BLS.
  • [F11]Louis Blumberg is the managing member of AFB. By virtue of Louis Blumberg's position as the managing member of AFB, Louis Blumberg may be deemed to beneficially own the securities held by AFB.
  • [F12]Laurence J. Blumberg is a member of AFB. By virtue of Laurence Blumberg's position as a member of AFB, Laurence Blumberg may be deemed to beneficially own the securities held by AFB.
  • [F13]Immediate.
  • [F14]Not applicable.
  • [F2]These securities are held by Blumberg Life Sciences Fund, L.P. ("BLSF").
  • [F3]These securities are held by Blumberg Life Sciences Fund, Ltd. ("BLS").
  • [F4]These securities are held by BLSF. Blumberg Capital Advisors, L.L.C., the general partner of BLSF, is deemed to beneficially own these securities by virtue of its position as general partner of BLSF.
  • [F5]These securities are held by AFB Fund LLC, a New Jersey limited liability company for which Louis Blumberg is the managing member and Laurence J. Blumberg is a member.
  • [F6]These securities are held by Laurence J. Blumberg.
  • [F7]These securities are held by AFB.
  • [F8]Blumberg Capital Management, L.L.C. ("BCM") has been delegated investment advisory responsibilities by Blumberg Capital Advisors, L.L.C. ("BCA"), the general partner of BLSF, BCM may be deemed to beneficially own the securities held by BLSF by virtue of BCM's position as investment manager of BLSF.
  • [F9]BCM may be deemed to beneficially own the securities held by BLS by virtue of BCM's position as investment manager of BLS.

Documents

1 file

Issuer

CAMBRIDGE HEART INC

CIK 0000913443

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000913443

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 2:17 PM ET
Size
20.0 KB
View on SEC.gov